12
Participants
Start Date
November 30, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
September 30, 2014
Maraviroc
Twelve patients with 300 mg/bid
National Center for Tumor Diseases, Department of Medical Oncology, Heidelberg
University Hospital Heidelberg
OTHER
National Center for Tumor Diseases, Heidelberg
OTHER